Co-Authors
This is a "connection" page, showing publications co-authored by Yaoxing Huang and Hengrui Liu.
Connection Strength
0.177
-
Inhibitors of Coronavirus 3CL Proteases Protect Cells from Protease-Mediated Cytotoxicity. J Virol. 2021 06 24; 95(14):e0237420.
Score: 0.060
-
Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nat Commun. 2021 May 05; 12(1):2708.
Score: 0.059
-
Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors. Nat Commun. 2021 04 01; 12(1):2016.
Score: 0.059